Stock Taper Revenue: Approximately $648 million, a 15.9% increase year-over-year.
Adjusted EBITDA: $84.4 million, a 25.2% increase compared to the previous year.
Gross Margin: Consolidated gross margin at 31.7%, with specific segments reporting:
Private Duty Services: 27.9%
Home Health and Hospice: 53.7%
Medical Solutions: 44.7%
Caregiver Hiring: Improvement in hiring and retention trends noted, attributed to enhanced reimbursement rates and preferred payer agreements.
Acquisition: Announced the acquisition of Family First Homecare, expected to close in late Q2 2026, aimed at enhancing pediatric care offerings.
Preferred Payer Strategy: Continued success with preferred payer agreements, achieving 60% of Private Duty Services MCO volumes from these contracts. Four new agreements signed in Q1, with a goal of 38 total by year-end.
Operational Efficiencies: Focus on automation and AI to improve operational efficiency, particularly in revenue cycle management (RCM).
Clinical Outcomes: Investments in clinical programs have led to improved patient satisfaction and strong TPS scores, contributing to financial performance.
2026 Guidance: Increased revenue guidance to a range of $2.56 billion to $2.58 billion and adjusted EBITDA guidance to $328 million to $332 million. This outlook does not include the impact of the Family First acquisition.
Growth Expectations: Anticipated mid-single-digit growth for Medical Solutions in the near term, with expectations for double-digit growth by year-end.
Regulatory Environment: A recent CMS announcement regarding a six-month moratorium on new Medicare licensure for home health may impact the industry, though management indicated no direct effect on Aveanna's operations or growth plans.
Labor Market Challenges: While improvements in caregiver hiring are noted, the overall labor market remains a challenge, and the company continues to navigate wage pressures.
Market Saturation: The company anticipates a moderation in government rate wins, which may affect growth in certain segments.
Regulatory Impact: Management reassured that the Medicare moratorium would not affect Aveanna's business model or growth strategy.
Preferred Payer Contracts: The majority of revenue growth is expected to be volume-driven rather than rate-driven, with wage pass-throughs impacting margins.
Technology and Automation: Continued focus on leveraging AI and automation in RCM is expected to yield further operational efficiencies, though it is still early in the implementation phase.
Future Acquisitions: Management remains open to small tuck-in acquisitions post-Family First, while maintaining a focus on deleveraging. Overall, Aveanna Healthcare demonstrated strong financial performance in Q1 2026, with a focus on strategic growth through preferred payer agreements and acquisitions, while navigating challenges in the regulatory landscape and labor market.
SOURCE: Q1 2026 EARNINGS CALL TRANSCRIPT